Piramal Pharma Solutions (PPS), part of Piramal Enterprises, has appointed John Fowler as its COO.
On Sep. 7, 2017, Piramal Pharma Solutions (PPS), part of Piramal Enterprises, has appointed John Fowler as its new COO. Fowler will be responsible for global operations and research & development (R&D).
Vivek Sharma, CEO at PPS, said in a company press release, “As PPS enters into the next phase of its rapid growth, it is important that we bring in seasoned executives with international experience and expertise. Over a distinguished career of nearly three decades, John has successfully led several global businesses, streamlined operations, developed and implemented commercial strategies that have increased profitability while driving growth, and has aligned focus of R&D team with long term business requirements.”
Most recently, Fowler served as the divisional CEO of the global fine chemicals business at Johnson Matthey.
Source: PPS
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.